Medicare Part B Immunosuppressive Drug (Part B-ID)
Description
This memo announces the new federal Medicare Part B Immunosuppressive Drug (Part B-ID) benefit and clarifies policies on a Medicare Part B-ID beneficiary’s eligibility for Medicare Savings Programs (MSP), Medicaid and BadgerCare Plus.
Memo Issued By
DMS
Official Memo Number
23-13
Memo Issue Date
April 28, 2023
Memo File